People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bright Minds Biosciences Inc. | — | Biotechnology | Series B | $37.4M | $212.9M | 2022 |
Nils Torleif Bottler at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nils Torleif Bottler on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ryan Cheung | 1 | 7 |
| Ian McDonald | 1 | 2 |
| Emer Leahy | 1 | 2 |
| Jan Torleif Pedersen | 1 | 1 |
| Jeremy M Fryzuk | 1 | 1 |
| Nils M Bottler | 1 | 1 |
| Jeremy Fryzuk | 1 | 1 |
| Revati Shreeniwas | 1 | 1 |
| Douglas Williamson | 1 | 1 |
| Alan Kozikowski | 1 | 1 |
| Nils Bottler | 1 | 1 |
| Revati Sheeniwas | 1 | 1 |
| Gideon Shapiro | 1 | 1 |
| David M Weiner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.